Assessment of atrial septal defects using 3-dimensional transthoracic echocardiography prior to percutaneous device closure: first report from Bangladesh
Therapeutic Advances in Cardiovascular Disease · 2023
DOI: 10.1177/17539447231193290 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Advances in Cardiovascular Disease, 2023. Verfasst von Santosh Kumar Saha und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Cardiology, National Institute of Cardiovascular Diseases and Hospital, Sher-e- Bangla Nagar, Dhaka 1207, Bangladesh. Hauptthemen laut MEDLINE: Echocardiography, Three-Dimensional, Heart Septal Defects, Atrial, Septal Occluder Device. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Secundum atrial septal defect (ASD) is treated following trans-catheter closure in alternative to surgical treatment. Per-intervention selection of device size with balloon occlusive diameter (BOD) often cause tearing or enlarging, causing arrhythmias and hypotension. We assessed the suitability of percutaneous device closure for ASD using 3-dimensional transthoracic echocardiography (3DTTE).
Objectives
This study was conducted to investigate if 3DTTE could be an alternative of balloon sizing for selection of device size in atrial septal defect device closure.
Design
It was a cross-sectional comparative study.
Methods
This study was conducted at the department of Pediatric Cardiology, Bangabandhu Sheikh Mujib Medical University for a period of 2 years. Thirty-three purposively selected secundum ASD patients suitable for device closure were included in the study. Ethical permission was taken from the Institutional Review Board and written consent was taken from each patient’s guardian. In this study, 3DTTE derived ASD diameter and BOD were compared with that of deployed device size using correlation analysis.
Results
Out of 33 patients, 63.6% were female and 36.4% were males had a mean age of 18.07 ± 14.58 years (range 2–55 years). Mean diameter of ASD measured by 2-dimensional (2D) and 3-dimensional (3D) echocardiography were 17.09 ± 6.08 mm and 21.30 ± 6.56 mm, respectively, yielding a significant difference ( p < 0.001). 3D echocardiography derived ASDs diameter were highly correlated with device size than BOD and 2D echocardiography derived diameter (2D echocardiography: r = 0.796, p =
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Cardiology, National Institute of Cardiovascular Diseases and Hospital, Sher-e- Bangla Nagar, Dhaka 1207, Bangladesh.
- Department of Cardiology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
- Department of Cardiology, National Heart Foundation Hospital and Research Institute, Dhaka, Bangladesh.
- Department of Epidemiology and Research, National Heart Foundation Hospital and Research Institute, Dhaka, Bangladesh.
- Department of Pediatric Cardiology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
ORCID-Profile: Santosh Kumar Saha
Zitieren
APA
Saha, S. K., Ahmed, C. M., Haque, T., Al Mamun, M. A., & Hussain, M. Z. (2023). Assessment of atrial septal defects using 3-dimensional transthoracic echocardiography prior to percutaneous device closure: first report from Bangladesh. Therapeutic Advances in Cardiovascular Disease. https://doi.org/10.1177/17539447231193290
Vancouver
Saha SK, Ahmed CM, Haque T, Al Mamun MA, Hussain MZ. Assessment of atrial septal defects using 3-dimensional transthoracic echocardiography prior to percutaneous device closure: first report from Bangladesh. Therapeutic Advances in Cardiovascular Disease. 2023. doi:10.1177/17539447231193290
BibTeX
@article{Saha2023,
author = {Saha, Santosh Kumar and Ahmed, Chaudhury Meshkat and Haque, Tuhin and Al Mamun, Mohammad Abdullah and Hussain, Mohd Zahid},
title = {Assessment of atrial septal defects using 3-dimensional transthoracic echocardiography prior to percutaneous device closure: first report from Bangladesh},
journal = {Therapeutic Advances in Cardiovascular Disease},
year = {2023},
doi = {10.1177/17539447231193290}
}
EUVIMED